<DOC>
	<DOCNO>NCT00892398</DOCNO>
	<brief_summary>Trabeculectomy mitomycin C remain standard surgery glaucoma . This surgery involve create door eye wall order improve fluid outflow decrease intraocular pressure . However , success rate range 70 % 90 % depend criterion use tend decrease time . The failure surgery associate inflammation , new blood vessel formation scar cause closure door . Molecules inhibit new blood vessel formation inhibitor vascular endothelial growth factor use successfully decrease scar animal eye little door create significantly improve survival . Furthermore , show promise use trabeculectomy . Ranibizumab , vascular endothelial growth factor , also use safely intraocular surgery treat disease involve new blood vessel formation macular degeneration diabetes . The investigator hypothesize ranibizumab may decrease failure rate trabeculectomy mitomycin C decrease scar . The aim study evaluate difference failure rate bleb morphology one year post-operatively eye undergone sub-conjunctival injection ranibizumab addition primary trabeculectomy mitomycin C compare eye undergone trabeculectomy mitomycin C alone .</brief_summary>
	<brief_title>Trabeculectomy With Mitomycin C Associated With Sub-conjunctival Injection Ranibizumab</brief_title>
	<detailed_description>Prospective , randomize , unblinded clinical trial . Two group patient glaucoma undergoing primary trabeculectomy phaco-trabeculectomy MMC March 2009 September 2012 . The ranibizumab group ( RAN ) receive 2 subconjunctival injection 0.5 mg ranibizumab ( intraoperatively day 14 ) control group receive ranibizumab .</detailed_description>
	<mesh_term>Mitomycin</mesh_term>
	<mesh_term>Mitomycins</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<criteria>uncontrolled glaucoma accept undergo primary trabeculectomy mitomycin C one follow type glaucoma : Normal tension Glaucoma Chronic OpenAngle Glaucoma Chronic AngleClosure Glaucoma Mixed mechanism glaucoma Steroidinduced Glaucoma Neovascular Glaucoma le 18 year old unable observe study protocol present risk factor thromboembolic event cerebrovascular accident : hypertension , dyslipidemia , coronary artery diseases history thromboembolic event cerebrovascular accident congenital glaucoma uveitic glaucoma pregnant breastfeed surgical complication prior injection study drug vitreous anterior chamber presence suprachoroidal hemorrhage undergone previous conjunctival surgery hypersensitive drug , one component drug one component package present active suspect intraocular periocular inflammation kidney failure liver failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Trabeculectomy</keyword>
	<keyword>Vascular Endothelial Growth Factor A</keyword>
	<keyword>Wound Healing</keyword>
	<keyword>Angiogenesis Inhibitors</keyword>
</DOC>